PURPLESUN Battles the Invisible Enemy – COVID-19 – There is Light

Company in Partnership with Hackensack Meridian Health and Northwell Health Form a Private Sector Partnership to Provide FMUV Shadowless Delivery Light Decontamination Technology to Government Agencies

September 23, 2020

PURPLESUN Inc. is a technology company on a mission to transform healthcare and provide a sustainable impact for the healthiest environments. Amid the COVID-19 crisis, there is light.

PurpleSun designs and manufactures hospital-grade mechatronic systems that are user friendly and provide a special type of Focused Multivector Ultraviolet (FMUV) light technology, for the purpose of disinfection in 90 seconds.

The company uses proprietary FMUV – focused light energy to improve germicidal effectiveness and speed – to quickly kill off organisms, as proven by several top publications, including the American Journal of Infection Control.

After extensive electrical and ultraviolet light emission testing, including risk mitigation analysis, the PurpleSun E300 was certified to the Standard, IEC 61010-1, by Underwriters Laboratory. The E300 modular and mobile PurpleSun system can be used to treat equipment and rooms while people continue to work around the system safely.

With a community of innovative minds from top executives, clinicians and board members at Hackensack Meridian Health, Northwell Health, and PurpleSun — the trio collaborated to provide access to PurpleSun technology to government agencies in order to help protect the crew and pilots to maximize operational readiness of their no-fail mission criteria.

At Hackensack Meridian Health, a leading not-for-profit health care organization that is the most comprehensive and truly integrated health care network in New Jersey. “We’re proud to help our crew members protect against the common enemy, COVID-19,” said Robert C. Garrett, CEO of Hackensack Meridian Health. “PurpleSun was one of the first investments made through our innovative Bear’s Den incubator program. Now that we’re in the thick of this pandemic, the choice of such an innovative disinfection technology seems more prescient than ever.”

At Northwell Health is New York State’s largest health care provider. “PurpleSun has played an important role in our fight against COVID-19. When the call came to support this initiative, the team stepped up to make the partnership happen – yet another testament to the culture at Northern Westchester Hospital and Northwell Health. Northern Westchester Hospital, along with Staten Island University Hospital and Cohen Children’s Medical Center were the first hospitals to purchase and use PurpleSun in our efforts to enhance disinfection. Having purchased multiple devices, we were able and proud to extend the technology to the government to protect their pilots and crew during this time of crisis,” said Derek Anderson, Executive Director of Northern Westchester Hospital.

SourcePURPLESUN

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.